MedPath

Insulin sensitisation to delay pubertal progression in girls: a pilot study in small-for-gestational-age (SGA) girls with an early-normal onset of puberty

Completed
Conditions
Advanced and progressive puberty in low-birthweight girls, resulting in final height below target
Urological and Genital Diseases
Puberty
Registration Number
ISRCTN06805028
Lead Sponsor
Hospital Sant Joan de Deu (Spain)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
22
Inclusion Criteria

1. Birthweight for gestational age below -1.5 standard deviation (SD)
2. Onset of breast development (Tanner stage 2, B2) between age 8-9 years and <12 months before study start
3. Height SD score (SDS) at enrollment at least 1 SD above mid-parental height
4. Height velocity >6 cm/year
5. Progressive puberty, as assessed by pelvic ultrasonography and by gonadotropin and steroid responses to gonadotropin releasing hormone (GnRH) agonist stimulation

Exclusion Criteria

A family or personal history of diabetes mellitus; a history of precocious pubarche; evidence for thyroid dysfunction, Cushing syndrome, hyperprolactinemia or glucose intolerance; medication known to affect gonadal function or carbohydrate metabolism.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Menarche<br>2. Final height
Secondary Outcome Measures
NameTimeMethod
1. Fasting insulin<br>2. IGF-I
© Copyright 2025. All Rights Reserved by MedPath